If you need more lookups,
subscriptions start at $34 USD/month.
Francesca Barone Location
United States
Francesca Barone Work
2025 -now Scientific Advisor @
2022 -now Chief Scientific Officer @
2020 -2022 Vice President, Head of Research @
2019 -2020 Vice President of Experimental Medicine @ Kintai Therapeutics
2019 -2020 Head of Experimental Medicine @ Kintai Therapeutics
2018 -2019 Director of Business Engagement College of MDS University of Birmingham @
2017 -2019 Reader in Translational Rheumatology @
2010 -2019 Clinician Scientist, Consultant in Rheumatology @
2007 -2010 Research Associate @ Dep. Immunobiology Kings College London
Francesca Barone Education
Kings College London
Doctor of Philosophy (Ph.D.) (Medicine)
2008
Università degli Studi di Roma 'La Sapienza'
Specialization in Rheumatology (Medicine)
2007
Università degli Studi di Roma 'La Sapienza'
Doctor of Medicine (MD) (Medicine)
2001
Francesca Barone Skills
Research and Development (R&D)
Pre-clinical Studies
In Vivo
Immunotherapy
Global Perspective
Clinical Development
Oncology
Drug Development
Cancer Immunotherapy
Cell Biology
Clinical Research
Immunology
Molecular Biology
Cell Culture
Rheumatology
Cell
Life Sciences
Science
Research
Flow Cytometry
Italian
Inflammation
Francesca Barone Summary
Francesca Barone, based in United States, is currently a Chief Scientific Officer at Candel Therapeutics. Francesca Barone brings experience from previous roles at Marseille Immunology Biocluster, Candel Therapeutics and Kintai Therapeutics. Francesca Barone holds a Doctor of Philosophy (Ph.D.) in Medicine @ Kings College London. With a robust skill set that includes Research and Development (R&D), Pre-clinical Studies, In Vivo, Immunotherapy, Global Perspective and more. Francesca Barone has 2 emails and 5 mobile phone numbers on RocketReach.
Looking for a different Francesca Barone?
Find contact details for 700 million professionals.